LICENSE AGREEMENT between SANOFI and VALO HEALTH, INC. Dated as of May 10, 2021License Agreement • October 20th, 2021 • Khosla Ventures Acquisition Co. • Pharmaceutical preparations • New York
Contract Type FiledOctober 20th, 2021 Company Industry JurisdictionThis License Agreement (this “Agreement”) is made and entered into as of May 10, 2021 (the “Effective Date”) by and between Sanofi, a French corporation, having offices at 54, rue la Boétie, 75008 Paris (“Sanofi” or “Licensor”), and, Valo Health, Inc., a Delaware corporation, with a principal office at 399 Boylston Street, Suite 505, Boston, MA 02116 (“Valo” or “Licensee”). Sanofi and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.